Ads
related to: myeloid leukemia cells- Efficacy
Durable Complete Remissions
for R/R AML Patients.
- Access & Resources
Support is Available for
You and Your Patients.
- Safety
Learn More About Well Characterized
Safety Profile.
- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Efficacy
Search results
Valrubicin-loaded immunoliposomes: A new technology to fight hematological cancer
Medical Xpress· 2 days agoValrubicin, a lipophilic chemical molecule similar to daunorubicin, has primarily been used in the treatment of bladder cancer. An article recently published in Cell Death ...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 6 days agoThe approach isn’t entirely new: The first antibody drug conjugate was approved by the Food and Drug...
MD Anderson Research Highlights for June 5, 2024 | Newswise
Newswise· 3 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological...
Benzinga· 1 day agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin
Steps To-Marrow: Grandmother walks hundreds of miles to raise donor awareness
The Wenatchee World· 2 days agoJeana Moore, 71, is not singing “I’m Gonna Be,” but she is walking hundreds of miles, thousands one...
'Smart warheads' of cancer: Experts' excitement for treatment approach grows
Becker’s Hospital Review· 5 days agoCancer experts are increasingly optimistic about the potential for antibody-drug conjugates to become a standard treatment approach. The therapies involve attaching chemotherapy to an antibody ...
How a protein component of nuclear pore complexes | Newswise
Newswise· 3 days agoNuclear pore complexes (NPCs) are channels composed of multiple proteins that ferry molecules in and...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 4 days agoLive from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire SUZHOU, China ...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 17 hours agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
FDA Approves Imetelstat for Rare Low-Risk Blood Cancer
Medscape· 1 day agoThe approval for the first-in-class agent is "potentially practice changing" given the lack of treatment options for transfusion-dependent lower-risk MDS patients.
Ads
related to: myeloid leukemia cells